期刊文献+

影响缺血性心肌病血运重建后左心室射血分数的多因素分析 被引量:5

Multiple factors analysis on the recovery of left ventricular ejection fraction in the revascularized patients with ischaemic cardiomyopathy
原文传递
导出
摘要 目的探讨如何筛选出血运重建后左心室射血分数(LVEF)明显增加的缺血性心肌病(ischaemic cardiomyopathy,ICM)患者。方法回顾性分析我院2010年7月至2015年12月期间,245例行冠状动脉旁路移植术(coronary bypass grafting,CABG)(30%≤LVEF≤40%),其中合并缺血性二尖瓣反流146例(146/245,59.6%),有41例患者因中度以上的缺血性二尖瓣反流而同时行二尖瓣成形术/置换术。围术期死亡13例(12例为CABG+二尖瓣成形术或置换术,1例为单纯行CABG术),余232例随访6个月以上为研究对象,根据术后LVEF是否增加10%分为两组,即LVEF恢复组(A组)124例,LVEF不恢复组(B组)108例。结果单因素分析发现A组术前NT-proBNP值明显高于B组(P=0.036),有心肌梗死病史的比例明显低于B组(P=0.047),而术前仍有心绞痛的比例明显高于B组(P=0.024)。两组之间的二尖瓣反流程度及二尖瓣成形术或置换术比例差异无统计学意义(P=0.199)。A组患者的左心室舒张期末内径(LVEDD)、左心室收缩期末内径(LVESD)、左室舒张期末容积(LVEDV)均明显低于B组(P<0.05)。多因素分析发现LVEDD明显增大、术前无明显心绞痛是ICM(30%≤LVEF≤40%)患者行血运重建后LVEF不能恢复的术前危险因素。以245例患者(包括13例围术期死亡患者)为研究对象,其LVEDD为41~71 mm,发现LVEDD≥60 mm与ICM患者的预后不良有显著关系(χ2=8.63,P=0.003,OR=2.21,95%CI 1.25~3.91)。结论发现LVEDD明显增大、术前无明显心绞痛是ICM(30%≤LVEF≤40%)患者行血运重建后LVEF不能恢复的术前危险因素。LVEDD≥60 mm可以作为ICM(30%≤LVEF≤40%)患者预后不良的术前临床筛选指标之一。 Objective We probed how to predict left ventricular ejection fraction(LVEF) of the ischaemic cardiomyopathy(ICM) patients would be improved apparently after revascularization. Methods Between July 2010 and December 2015, 245 ICM patients(30%≤LVEF≤40%) with coronary bypass grafting(CABG) were retrospectively observed. Among them, 146 patients were accompanied by ischemic mitral regurgitation(IMR)(146/245, 59.6%), and 41 patients underwent mitral valvuloplasty or replacement because of more than moderate IMR. There were 13 patients early death, and other 232 patients who were followed up over 6 months were divided into two groups based on whether or not post-operative LVEF increased by 10%: a LVEF recovered group(group A, 124 patients) and a non-recovered group(group B, 108 patients). Results Preoperative NT-proBNP in the group A was significantly higher than that in the group B(P=0.036). There were less patients with myocardial infarction in the group A than that in the group B(P=0.047), and more with angina pectoris in the group A than that in the group B(P=0.024). There was no significant difference in the extent of mitral regurgitation or mitral surgery between the groups A and B(P>0.05). There were lower left ventricular end-diastolic diameter(LVEDD), left ventricular end-systolic diameter(LVESD) and left ventricular end-diastolic volume(LVEDV) in the group A than those in the group B(P<0.05). Multivariate analysis revealed that preoperative LVEDD dilated apparently and no angina pectoris existed before surgery were independent risk factors for LVEF with no recovery in the ICM patients(30%≤LVEF≤40%) after revascularization. The LVEDD of 245 patients(including 13 early deaths)was 41-71 mm. We found that the ICM patients with LVEDD ≥60 mm were more likely to signify the unfavourable prognosis(χ2=8.63, P=0.003, OR=2.21, 95% confidence interval 1.25 to 3.91). Conclusion Preoperative LVEDD dilated and no angina pectoris before surgery are independent risk factors for LVEF with no recovery in the ICM patients(30%≤LVEF≤40%) after revascularization. LVEDD≥60 mm can be regarded as the preoperative forecasting factors for the unfavourable prognosis in the ICM patients(30%≤LVEF≤40%) after revascularization.
作者 金岩 王辉山 姜辉 陶登顺 赵科研 于岩 赵洋 JIN Yan;WANG Huishan;JIANG Hui;TAO Dengshun;ZHAO Keyan;YU Yan;ZHAO Yang(Department of Cardiovascular Surgery,Military General Hospital of Northern Theater Command General Hospital,Shenyang,110016,P.R.China)
出处 《中国胸心血管外科临床杂志》 CAS CSCD 2018年第12期1043-1048,共6页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 国家自然科学基金项目(81500315) 辽宁省自然科学基金(201602772)
关键词 缺血性心肌病 冠状动脉旁路移植术 左室射血分数 左室舒张期末内径 Ischaemic cardiomyopathy coronary bypass grafting left ventricular ejection fraction left ventricular end-diastolic diameter
  • 相关文献

参考文献1

二级参考文献7

  • 1Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 2Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 3Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 4Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 5Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 6上海市心力衰竭调查协作组,范维琥,张平宽,李勇.上海市稳定性心力衰竭患者药物治疗现状调查[J].中华心血管病杂志,2001,29(11):644-648. 被引量:37
  • 7慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2414

共引文献361

同被引文献33

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部